
Beemnet W. Dada
Examiner (ID: 2134, Phone: (571)272-3847 , Office: P/2435 )
| Most Active Art Unit | 2435 |
| Art Unit(s) | 2135, 2435 |
| Total Applications | 1486 |
| Issued Applications | 1172 |
| Pending Applications | 108 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11230952
[patent_doc_number] => 09458172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/382123
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40361
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382123
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382123 | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives | Feb 28, 2013 | Issued |
Array
(
[id] => 9662414
[patent_doc_number] => 08809390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 13/779080
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5614
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13779080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/779080 | Compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient | Feb 26, 2013 | Issued |
Array
(
[id] => 8884909
[patent_doc_number] => 20130158093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'GPR 17 Agonists and Screening Assay'
[patent_app_type] => utility
[patent_app_number] => 13/775433
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20495
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775433
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775433 | GPR 17 Agonists and Screening Assay | Feb 24, 2013 | Abandoned |
Array
(
[id] => 9004731
[patent_doc_number] => 20130225856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'CONTINUOUS PROCESS FOR CONVERSION OF LIGNIN TO USEFUL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/775241
[patent_app_country] => US
[patent_app_date] => 2013-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27148
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775241
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775241 | CONTINUOUS PROCESS FOR CONVERSION OF LIGNIN TO USEFUL COMPOUNDS | Feb 23, 2013 | Abandoned |
Array
(
[id] => 8964205
[patent_doc_number] => 20130203807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'USE OF LAQUINIMOD FOR TREATING CROHN\'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNF THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/757004
[patent_app_country] => US
[patent_app_date] => 2013-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16379
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13757004
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/757004 | Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy | Jan 31, 2013 | Issued |
Array
(
[id] => 11427966
[patent_doc_number] => 09566270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Methods for treating irritable bowel syndrome (IBS)'
[patent_app_type] => utility
[patent_app_number] => 13/755578
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21270
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13755578
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/755578 | Methods for treating irritable bowel syndrome (IBS) | Jan 30, 2013 | Issued |
Array
(
[id] => 13645673
[patent_doc_number] => 09849135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => USP14 inhibitors for treating or preventing viral infections
[patent_app_type] => utility
[patent_app_number] => 14/761089
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 18373
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761089
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/761089 | USP14 inhibitors for treating or preventing viral infections | Jan 24, 2013 | Issued |
Array
(
[id] => 9793442
[patent_doc_number] => 20150005386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Methods of Reducing Risk of Cardiovascular Disease'
[patent_app_type] => utility
[patent_app_number] => 14/370722
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13068
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370722
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370722 | Methods of reducing risk of cardiovascular disease | Jan 3, 2013 | Issued |
Array
(
[id] => 8791594
[patent_doc_number] => 20130108563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'COMPOSITIONS COMPRISING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE WHICH COMPRISES AVERMECTIN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/720638
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6147
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13720638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/720638 | Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds | Dec 18, 2012 | Issued |
Array
(
[id] => 9786253
[patent_doc_number] => 20140303074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription'
[patent_app_type] => utility
[patent_app_number] => 14/360870
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11040
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/360870 | Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription | Dec 11, 2012 | Abandoned |
Array
(
[id] => 10160952
[patent_doc_number] => 09192163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Pest control composition'
[patent_app_type] => utility
[patent_app_number] => 14/354304
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6958
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354304
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354304 | Pest control composition | Dec 11, 2012 | Issued |
Array
(
[id] => 10926844
[patent_doc_number] => 20140329865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Pesticidal Mixtures'
[patent_app_type] => utility
[patent_app_number] => 14/365373
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33336
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/365373 | Pesticidal mixtures | Dec 11, 2012 | Issued |
Array
(
[id] => 15132611
[patent_doc_number] => 10479752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/363912
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13179
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363912 | Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof | Dec 5, 2012 | Issued |
Array
(
[id] => 8768156
[patent_doc_number] => 20130096193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'CREATINE BETA-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE'
[patent_app_type] => utility
[patent_app_number] => 13/691172
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6143
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13691172
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/691172 | CREATINE BETA-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE | Nov 29, 2012 | Abandoned |
Array
(
[id] => 9175112
[patent_doc_number] => 20130317097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'STABLE COMPOSITIONS OF DEHYDROASCORBIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/676815
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4935
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676815 | Stable compositions of dehydroascorbic acid | Nov 13, 2012 | Issued |
Array
(
[id] => 13207055
[patent_doc_number] => 10117878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Ligands for nematode nuclear receptors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 13/673696
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 42
[patent_no_of_words] => 19359
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673696 | Ligands for nematode nuclear receptors and uses thereof | Nov 8, 2012 | Issued |
Array
(
[id] => 9060012
[patent_doc_number] => 08546447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Treatment of acne using derivatives of 5-aminolevulinic acid'
[patent_app_type] => utility
[patent_app_number] => 13/673704
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9421
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673704
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673704 | Treatment of acne using derivatives of 5-aminolevulinic acid | Nov 8, 2012 | Issued |
Array
(
[id] => 9771101
[patent_doc_number] => 20140294764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'COMPOUNDS AND COMPOSITIONS USED TO EPIGENETICALLY TRANSFORM CELLS AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 14/356024
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7788
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356024
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/356024 | Compounds and compositions used to epigenetically transform cells and methods related thereto | Nov 7, 2012 | Issued |
Array
(
[id] => 8708576
[patent_doc_number] => 20130065866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/670873
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8042
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/670873 | DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD | Nov 6, 2012 | Abandoned |
Array
(
[id] => 10135945
[patent_doc_number] => 09169259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-27
[patent_title] => 'Imidazopyridazine compounds'
[patent_app_type] => utility
[patent_app_number] => 13/665006
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54038
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/665006 | Imidazopyridazine compounds | Oct 30, 2012 | Issued |